Synthetic Bryostatin Analogues Activate the RasGRP1 Signaling Pathway

The functional properties of four diacylglycerol (DAG) analogues were compared using cell-signaling assays based on the protein RasGRP1, a DAG-regulated Ras activator. Compounds 1 and 2, synthetic analogues of bryostatin 1, were compared to authentic bryostatin 1 and phorbol 12-myristate-13-acetate...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 47; no. 26; pp. 6638 - 6644
Main Authors Stone, James C, Stang, Stacey L, Zheng, Yong, Dower, Nancy A, Brenner, Stacey E, Baryza, Jeremy L, Wender, Paul A
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 16.12.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The functional properties of four diacylglycerol (DAG) analogues were compared using cell-signaling assays based on the protein RasGRP1, a DAG-regulated Ras activator. Compounds 1 and 2, synthetic analogues of bryostatin 1, were compared to authentic bryostatin 1 and phorbol 12-myristate-13-acetate (PMA). The two “bryologues” were able to activate RasGRP1 signaling rapidly in cultured cells and isolated mouse thymocytes. They elicited expression of the T cell activation marker CD69 in human T cells. DAG analogues promptly recruited RasGRP1 to cell membranes, but they did not induce RasGRP1 proteolysis. Bryostatin 1 and compounds 1 and 2 appeared to be less potent than PMA at inducing aggregation of mouse thymocytes, a PKC-dependent, RasGRP1-independent response. In addition to sharing potential anticancer properties with bryostatin 1, compounds 1 and 2 might be clinically useful as modulators of the immune system.
Bibliography:ark:/67375/TPS-C7BPLBS7-X
istex:CB13E2510757283A9D0861E19D9DE367C2DDA351
ISSN:0022-2623
1520-4804
DOI:10.1021/jm0495069